@article{3109919, title = "Epidemiology of community-acquired pneumonia hospitalizations and associated complications before and after the implementation of the heptavalent pneumococcal conjugate vaccine in Athens, Greece", author = "Lagousi, T. and Papadatou, I. and Kopsidas, I. and Critselis, E. and Theodoridou, M. and Spoulou, V.", journal = "Journal of the Pediatric Infectious Diseases Society", year = "2015", volume = "4", number = "3", pages = "260-263", publisher = "Oxford University Press", issn = "2048-7193, 2048-7207", doi = "10.1093/jpids/pit088", keywords = "Pneumococcus vaccine; Pneumococcus vaccine, acute respiratory failure; adolescent; Article; bacterial virulence; child; community acquired pneumonia; empyema; Greece; hemolytic uremic syndrome; hospital admission; hospitalization; human; infant; lung abscess; pleura effusion; priority journal; retrospective study; septic shock; septicemia; systemic inflammatory response syndrome; vaccination; Community-Acquired Infections; diagnostic test; immunology; newborn; Pneumococcal Infections; pneumonia; preschool child; tertiary care center; vaccine immunogenicity, Child; Child, Preschool; Community-Acquired Infections; Diagnostic Tests, Routine; Greece; Heptavalent Pneumococcal Conjugate Vaccine; Humans; Immunogenicity, Vaccine; Infant; Infant, Newborn; Pneumococcal Infections; Pneumonia; Retrospective Studies; Tertiary Care Centers", abstract = "We determined the rates of community-acquired pneumonia (CAP)-associated hospitalizations and complications in Athens, over a period covering 4 years before and 4 years after the implementation of the 7-valent pneumococcal vaccine (PCV7) in Greece. PCV7 had no impact on pediatric CAP rates, whereas there was an increase in CAP-associated complications. © The Author 2014. Published by Oxford University Press on behalf of the Pediatric Infectious Diseases Society." }